105 results
ARS
2023 FY
TARS
Tarsus Pharmaceuticals Inc
26 Apr 24
Annual report to shareholders
4:27pm
and the success of our company by motivating such individuals to perform to the best of their abilities and achieve our objectives. Employee Development … important agencies and contractors due to limitations in employee resources or forced furlough of government employees; limitations in employee
8-K
EX-1.1
TARS
Tarsus Pharmaceuticals Inc
1 Mar 24
Tarsus Announces Proposed $100.0 Million Public Offering
5:26pm
(except for subsequent issuances, if any, pursuant to this Agreement, pursuant to reservations, agreements or employee benefit plans referred … is or was an employee or contractor of the Company or any of its subsidiaries and who is, was or is expected to be involved in the creation or development of any
424B5
TARS
Tarsus Pharmaceuticals Inc
1 Mar 24
Prospectus supplement for primary offering
5:17pm
the 2020 Plan; and
2,859,434 shares of common stock reserved for issuance under our 2020 Employee Stock Purchase Plan, or the 2020 ESPP, as of December 31 … for issuance under our 2020 Employee Stock Purchase Plan, or the 2020 ESPP, as of December 31, 2023, as well as any automatic increases in the number
424B5
TARS
Tarsus Pharmaceuticals Inc
29 Feb 24
Prospectus supplement for primary offering
5:08pm
of common stock reserved for future issuance under the 2020 Plan; and
2,859,434 shares of common stock reserved for issuance under our 2020 Employee … reserved for future issuance under the 2020 Plan; and
2,859,434 shares of common stock reserved for issuance under our 2020 Employee Stock Purchase Plan
S-3ASR
uij1up d5g
29 Feb 24
Automatic shelf registration
4:32pm
S-3ASR
EX-4.5
n0bkuw9
29 Feb 24
Automatic shelf registration
4:32pm
S-8
nf9iinppw
27 Feb 24
Registration of securities for employees
4:22pm
S-8
EX-23.1
ork776t7gp24dxd1
27 Feb 24
Registration of securities for employees
4:22pm
8-K
EX-1.1
efw21yy6z
2 Aug 23
Tarsus Announces Proposed $100.0 Million Underwritten Public Offering of
4:10pm
424B5
8c2s88hbdnzep8rm6
2 Aug 23
Prospectus supplement for primary offering
4:08pm